F048-0095 Screening compound: 4-[cyclohexyl(methyl)sulfamoyl]-N-{5-methyl-4H,5H,6H,7H-[1,3]thiazolo[5,4-c]pyridin-2-yl}benzamide

F048-0095 Screening compound: 4-[cyclohexyl(methyl)sulfamoyl]-N-{5-methyl-4H,5H,6H,7H-[1,3]thiazolo[5,4-c]pyridin-2-yl}benzamide
F048-0095 Screening compound: 4-[cyclohexyl(methyl)sulfamoyl]-N-{5-methyl-4H,5H,6H,7H-[1,3]thiazolo[5,4-c]pyridin-2-yl}benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F048-0095
4-[cyclohexyl(methyl)sulfamoyl]-N-{5-methyl-4H,5H,6H,7H-[1,3]thiazolo[5,4-c]pyridin-2-yl}benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F048-0095

Molecular Formula

C21H28N4O3S2 (C21 H28 N4 O3 S2)

Compound Name

4-[cyclohexyl(methyl)sulfamoyl]-N-{5-methyl-4H,5H,6H,7H-[1,3]thiazolo[5,4-c]pyridin-2-yl}benzamide

IUPAC name

4-[cyclohexyl(methyl)sulfamoyl]-N-{5-methyl-4H5H6H7H-[13]thiazolo[54-c]pyridin-2-yl}benzamide

SMILES

CN(C1CCCCC1)S(c(cc1)ccc1C(Nc1nc(CCN(C)C2)c2s1)=O)(=O)=O

InChI

InChI=1S/C21H28N4O3S2/c1-24-13-12-18-19(14-24)29-21(22-18)23-20(26)15-8-10-17(11-9-15)30(27,28)25(2)16-6-4-3-5-7-16/h8-11,16H,3-7,12-14H2,1-2H3,(H,22,23,26)

InChI Key

SYLRMDGNQCTNHU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD11986211

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

448.61

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.446

Distribution Coefficient, logD

3.446

Water Solubility, LogSw

-3.84

Polar Surface Area

70.862

Acid Dissociation Constant (pKa)

6.10

Base Dissociation Constant (pKb)

8.03

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

52.40

F048-0095 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

CNS Targets (44014 compounds)

GPCR Targeted Library (31838 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Nervous system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Kinases
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F048-0095 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F048-0095?
Check Price and Availability of F048-0095, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F048-0095 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F048-0095
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F048-0095
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F048-0095 available by request